US Stock MarketDetailed Quotes

BHC Bausch Health

Watchlist
  • 6.750
  • -0.060-0.88%
Close Mar 27 16:00 ET
  • 6.750
  • 0.0000.00%
Post 16:05 ET
2.48BMarket Cap-51.92P/E (TTM)

Bausch Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
9.91%9.63B
6.27%2.56B
12.15%2.51B
10.89%2.4B
10.75%2.15B
7.79%8.76B
9.80%2.41B
9.38%2.24B
10.17%2.17B
1.36%1.94B
Operating revenue
9.87%9.52B
6.13%2.53B
12.16%2.48B
10.86%2.38B
10.77%2.13B
7.95%8.66B
9.87%2.38B
9.45%2.21B
10.39%2.15B
1.64%1.92B
Cost of revenue
8.71%2.78B
3.12%727M
11.72%696M
10.79%719M
9.97%640M
8.25%2.56B
8.13%705M
6.68%623M
12.48%649M
5.63%582M
Gross profit
10.41%6.84B
7.57%1.83B
12.32%1.81B
10.94%1.68B
11.09%1.51B
7.60%6.2B
10.51%1.7B
10.47%1.62B
9.21%1.52B
-0.37%1.36B
Operating expense
8.50%4.99B
2.00%1.22B
14.63%1.29B
10.74%1.26B
6.84%1.22B
5.24%4.6B
7.14%1.2B
3.41%1.12B
2.71%1.14B
7.74%1.14B
Selling and administrative expenses
12.99%3.3B
7.05%820M
18.88%850M
17.02%832M
9.52%794M
11.12%2.92B
15.02%766M
8.17%715M
5.18%711M
16.56%725M
Research and development costs
1.99%616M
-4.61%145M
5.23%161M
0.00%156M
5.59%151M
14.18%604M
7.80%152M
15.04%153M
21.88%156M
12.60%143M
Depreciation amortization depletion
0.00%1.08B
-8.16%259M
8.30%274M
0.37%270M
0.37%274M
-11.36%1.08B
-9.90%282M
-12.76%253M
-10.93%269M
-11.94%273M
-Depreciation and amortization
0.00%1.08B
-8.16%259M
8.30%274M
0.37%270M
0.37%274M
-11.36%1.08B
-9.90%282M
-12.76%253M
-10.93%269M
-11.94%273M
Operating profit
15.88%1.85B
20.87%608M
7.09%529M
11.52%426M
33.03%294M
15.03%1.6B
19.48%503M
30.69%494M
34.51%382M
-28.25%221M
Net non-operating interest income expense
-4.07%-1.36B
7.87%-328M
-1.80%-339M
-9.62%-342M
-14.95%-346M
10.21%-1.3B
-18.27%-356M
12.83%-333M
23.34%-312M
16.39%-301M
Non-operating interest income
26.92%33M
28.57%9M
16.67%7M
14.29%8M
50.00%9M
85.71%26M
16.67%7M
100.00%6M
133.33%7M
200.00%6M
Non-operating interest expense
4.52%1.39B
-7.16%337M
2.06%346M
9.72%350M
15.64%355M
-9.29%1.33B
18.24%363M
-11.95%339M
-22.20%319M
-15.19%307M
Other net income (expense)
51.74%-332M
53.90%-71M
56.67%-211M
-500.00%-36M
69.64%-17M
-882.86%-688M
67.71%-154M
-209.93%-487M
250.00%9M
-86.67%-56M
Gain on sale of security
9.62%-47M
-50.00%-21M
----
47.62%-11M
-50.00%-15M
-550.00%-52M
-16.67%-14M
-200.00%-7M
-625.00%-21M
-42.86%-10M
Special income (charges)
55.12%-285M
64.29%-50M
56.04%-211M
-170.97%-22M
95.65%-2M
-2,251.85%-635M
67.37%-140M
-210.09%-480M
381.82%31M
-100.00%-46M
-Less：Restructuring and merger&acquisition
-64.83%51M
-91.49%4M
-49.09%28M
350.00%9M
-75.61%10M
130.16%145M
1,466.67%47M
292.86%55M
-93.33%2M
156.25%41M
-Less:Impairment of capital assets
-94.70%29M
-74.73%23M
--0
-86.49%5M
-92.31%1M
-34.80%547M
-85.37%91M
238.33%406M
-58.43%37M
62.50%13M
-Less:Other special charges
498.15%215M
2,200.00%23M
683.33%188M
112.68%9M
37.50%-5M
93.83%-54M
100.50%1M
104.21%24M
32.38%-71M
-700.00%-8M
-Gain on sale of property,plant,equipment
233.33%10M
--0
0.00%5M
200.00%1M
--4M
--3M
---1M
--5M
-133.33%-1M
--0
Other non- operating income (expenses)
----
----
----
-200.00%-3M
----
97.14%-1M
--0
----
-200.00%-1M
----
Income before tax
142.82%167M
3,085.71%209M
93.56%-21M
-39.24%48M
49.26%-69M
-202.33%-390M
98.04%-7M
-174.26%-326M
161.24%79M
-65.85%-136M
Income tax
8.14%239M
177.50%111M
26.79%71M
-5.77%49M
-89.04%8M
166.27%221M
-24.53%40M
55.56%56M
420.00%52M
556.25%73M
Net income
88.22%-72M
308.51%98M
75.92%-92M
-103.70%-1M
63.16%-77M
-188.21%-611M
88.54%-47M
-194.79%-382M
119.42%27M
-216.67%-209M
Net income continuous Operations
88.22%-72M
308.51%98M
75.92%-92M
-103.70%-1M
63.16%-77M
-188.21%-611M
88.54%-47M
-194.79%-382M
119.42%27M
-216.67%-209M
Minority interest income
-36.84%-26M
162.50%5M
-75.00%-7M
-1,200.00%-11M
-62.50%-13M
-246.15%-19M
-8M
-200.00%-4M
-83.33%1M
-366.67%-8M
Net income attributable to the parent company
92.23%-46M
338.46%93M
77.51%-85M
-61.54%10M
68.16%-64M
-163.11%-592M
90.49%-39M
-194.74%-378M
117.93%26M
-191.30%-201M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
92.23%-46M
338.46%93M
77.51%-85M
-61.54%10M
68.16%-64M
-163.11%-592M
90.49%-39M
-194.74%-378M
117.93%26M
-191.30%-201M
Basic earnings per share
91.98%-0.13
327.27%0.25
77.67%-0.23
-57.14%0.03
69.09%-0.17
-161.29%-1.62
90.27%-0.11
-193.64%-1.03
117.50%0.07
-189.47%-0.55
Diluted earnings per share
91.98%-0.13
327.27%0.25
77.67%-0.23
-57.14%0.03
69.09%-0.17
-161.29%-1.62
90.27%-0.11
-193.64%-1.03
117.50%0.07
-189.47%-0.55
Dividend per share
0
0
0
0
0
0
0
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 9.91%9.63B6.27%2.56B12.15%2.51B10.89%2.4B10.75%2.15B7.79%8.76B9.80%2.41B9.38%2.24B10.17%2.17B1.36%1.94B
Operating revenue 9.87%9.52B6.13%2.53B12.16%2.48B10.86%2.38B10.77%2.13B7.95%8.66B9.87%2.38B9.45%2.21B10.39%2.15B1.64%1.92B
Cost of revenue 8.71%2.78B3.12%727M11.72%696M10.79%719M9.97%640M8.25%2.56B8.13%705M6.68%623M12.48%649M5.63%582M
Gross profit 10.41%6.84B7.57%1.83B12.32%1.81B10.94%1.68B11.09%1.51B7.60%6.2B10.51%1.7B10.47%1.62B9.21%1.52B-0.37%1.36B
Operating expense 8.50%4.99B2.00%1.22B14.63%1.29B10.74%1.26B6.84%1.22B5.24%4.6B7.14%1.2B3.41%1.12B2.71%1.14B7.74%1.14B
Selling and administrative expenses 12.99%3.3B7.05%820M18.88%850M17.02%832M9.52%794M11.12%2.92B15.02%766M8.17%715M5.18%711M16.56%725M
Research and development costs 1.99%616M-4.61%145M5.23%161M0.00%156M5.59%151M14.18%604M7.80%152M15.04%153M21.88%156M12.60%143M
Depreciation amortization depletion 0.00%1.08B-8.16%259M8.30%274M0.37%270M0.37%274M-11.36%1.08B-9.90%282M-12.76%253M-10.93%269M-11.94%273M
-Depreciation and amortization 0.00%1.08B-8.16%259M8.30%274M0.37%270M0.37%274M-11.36%1.08B-9.90%282M-12.76%253M-10.93%269M-11.94%273M
Operating profit 15.88%1.85B20.87%608M7.09%529M11.52%426M33.03%294M15.03%1.6B19.48%503M30.69%494M34.51%382M-28.25%221M
Net non-operating interest income expense -4.07%-1.36B7.87%-328M-1.80%-339M-9.62%-342M-14.95%-346M10.21%-1.3B-18.27%-356M12.83%-333M23.34%-312M16.39%-301M
Non-operating interest income 26.92%33M28.57%9M16.67%7M14.29%8M50.00%9M85.71%26M16.67%7M100.00%6M133.33%7M200.00%6M
Non-operating interest expense 4.52%1.39B-7.16%337M2.06%346M9.72%350M15.64%355M-9.29%1.33B18.24%363M-11.95%339M-22.20%319M-15.19%307M
Other net income (expense) 51.74%-332M53.90%-71M56.67%-211M-500.00%-36M69.64%-17M-882.86%-688M67.71%-154M-209.93%-487M250.00%9M-86.67%-56M
Gain on sale of security 9.62%-47M-50.00%-21M----47.62%-11M-50.00%-15M-550.00%-52M-16.67%-14M-200.00%-7M-625.00%-21M-42.86%-10M
Special income (charges) 55.12%-285M64.29%-50M56.04%-211M-170.97%-22M95.65%-2M-2,251.85%-635M67.37%-140M-210.09%-480M381.82%31M-100.00%-46M
-Less：Restructuring and merger&acquisition -64.83%51M-91.49%4M-49.09%28M350.00%9M-75.61%10M130.16%145M1,466.67%47M292.86%55M-93.33%2M156.25%41M
-Less:Impairment of capital assets -94.70%29M-74.73%23M--0-86.49%5M-92.31%1M-34.80%547M-85.37%91M238.33%406M-58.43%37M62.50%13M
-Less:Other special charges 498.15%215M2,200.00%23M683.33%188M112.68%9M37.50%-5M93.83%-54M100.50%1M104.21%24M32.38%-71M-700.00%-8M
-Gain on sale of property,plant,equipment 233.33%10M--00.00%5M200.00%1M--4M--3M---1M--5M-133.33%-1M--0
Other non- operating income (expenses) -------------200.00%-3M----97.14%-1M--0-----200.00%-1M----
Income before tax 142.82%167M3,085.71%209M93.56%-21M-39.24%48M49.26%-69M-202.33%-390M98.04%-7M-174.26%-326M161.24%79M-65.85%-136M
Income tax 8.14%239M177.50%111M26.79%71M-5.77%49M-89.04%8M166.27%221M-24.53%40M55.56%56M420.00%52M556.25%73M
Net income 88.22%-72M308.51%98M75.92%-92M-103.70%-1M63.16%-77M-188.21%-611M88.54%-47M-194.79%-382M119.42%27M-216.67%-209M
Net income continuous Operations 88.22%-72M308.51%98M75.92%-92M-103.70%-1M63.16%-77M-188.21%-611M88.54%-47M-194.79%-382M119.42%27M-216.67%-209M
Minority interest income -36.84%-26M162.50%5M-75.00%-7M-1,200.00%-11M-62.50%-13M-246.15%-19M-8M-200.00%-4M-83.33%1M-366.67%-8M
Net income attributable to the parent company 92.23%-46M338.46%93M77.51%-85M-61.54%10M68.16%-64M-163.11%-592M90.49%-39M-194.74%-378M117.93%26M-191.30%-201M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 92.23%-46M338.46%93M77.51%-85M-61.54%10M68.16%-64M-163.11%-592M90.49%-39M-194.74%-378M117.93%26M-191.30%-201M
Basic earnings per share 91.98%-0.13327.27%0.2577.67%-0.23-57.14%0.0369.09%-0.17-161.29%-1.6290.27%-0.11-193.64%-1.03117.50%0.07-189.47%-0.55
Diluted earnings per share 91.98%-0.13327.27%0.2577.67%-0.23-57.14%0.0369.09%-0.17-161.29%-1.6290.27%-0.11-193.64%-1.03117.50%0.07-189.47%-0.55
Dividend per share 0000000000
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+9.60%
Hutchmed (China)
HCM
+7.31%
eBay
EBAY
+1.88%
Enerpac Tool
EPAC
+1.56%
Halozyme Therapeutics
HALO
+1.03%

Unlock the Full List